M. Atkinson, G. Eisenbarth, and A. Michels, Type 1 diabetes, The Lancet, vol.383, issue.9911, pp.69-82, 2014.
DOI : 10.1016/S0140-6736(13)60591-7

J. Diana, Y. Simoni, L. Furio, L. Beaudoin, B. Agerberth et al., Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes, Nature Medicine, vol.169, issue.1, pp.65-73, 2013.
DOI : 10.1093/intimm/7.5.877

A. Lehuen, J. Diana, P. Zaccone, and A. Cooke, Immune cell crosstalk in type 1 diabetes, Nature Reviews Immunology, vol.286, issue.7, pp.501-514, 2010.
DOI : 10.1038/nri2787

A. Willcox, S. Richardson, A. Bone, A. Foulis, and N. Morgan, Analysis of islet inflammation in human type 1 diabetes, Clinical & Experimental Immunology, vol.37, issue.2, pp.173-81, 2009.
DOI : 10.1111/j.1365-2249.2008.03860.x

T. Delovitch and B. Singh, The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD, Immunity, vol.7, issue.6, pp.727-765, 1997.
DOI : 10.1016/S1074-7613(00)80392-1

M. Anderson and J. Bluestone, THE NOD MOUSE: A Model of Immune Dysregulation, Annual Review of Immunology, vol.23, issue.1, pp.447-85, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115643

Y. Zhen, L. Sun, H. Liu, K. Duan, C. Zeng et al., Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes, Cellular and Molecular Immunology, vol.172, issue.1, pp.75-85, 2012.
DOI : 10.1371/journal.pone.0007848

R. Mahler and M. Adler, Type 2 Diabetes Mellitus: Update on Diagnosis, Pathophysiology, and Treatment, The Journal of Clinical Endocrinology & Metabolism, vol.84, issue.4, pp.1165-71, 1999.
DOI : 10.1210/jcem.84.4.5612

S. Kahn, M. Cooper, D. Prato, and S. , Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future, The Lancet, vol.383, issue.9922, pp.1068-83, 2014.
DOI : 10.1016/S0140-6736(13)62154-6

A. Bendelac, M. Rivera, S. Park, and J. Roark, MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function, Annual Review of Immunology, vol.15, issue.1, pp.535-62, 1997.
DOI : 10.1146/annurev.immunol.15.1.535

A. Bendelac, P. Savage, and L. Teyton, The Biology of NKT Cells, Annual Review of Immunology, vol.25, issue.1, pp.297-336, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141711

Y. Simoni, D. J. Ghazarian, L. Beaudoin, L. Lehuen, and A. , Therapeutic manipulation of natural killer (NK)???T cells in autoimmunity: are we close to reality?, Clinical & Experimental Immunology, vol.18, issue.1, pp.8-19, 2013.
DOI : 10.1111/j.1365-2249.2012.04625.x

A. Jahng, I. Maricic, C. Aguilera, S. Cardell, R. Halder et al., Prevention of Autoimmunity by Targeting a Distinct, Noninvariant CD1d-reactive T Cell Population Reactive to Sulfatide, The Journal of Experimental Medicine, vol.160, issue.7, pp.947-57, 2004.
DOI : 10.1038/35097097

P. Arrenberg, R. Halder, Y. Dai, I. Maricic, and V. Kumar, Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid

E. Treiner, L. Duban, S. Bahram, M. Radosavljevic, V. Wanner et al., Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1, Nature, vol.107, issue.6928, pp.164-173, 2003.
DOI : 10.1126/SCIENCE.1069639

J. Diana and A. Lehuen, NKT cells: Friend or foe during viral infections?, European Journal of Immunology, vol.5, issue.12, pp.3283-91, 2009.
DOI : 10.1002/eji.200939800

E. Tupin, Y. Kinjo, and M. Kronenberg, The unique role of natural killer T cells in the response to microorganisms, Nature Reviews Microbiology, vol.8, issue.6, pp.405-422, 2007.
DOI : 10.1038/nrmicro1657

N. Cohen, S. Garg, and M. Brenner, Chapter 1 Antigen Presentation by CD1, Adv Immunol, vol.102, pp.1-94, 2009.
DOI : 10.1016/S0065-2776(09)01201-2

M. Mieza, T. Itoh, J. Cui, Y. Makino, T. Kawano et al., Selective reduction of V alpha 14þ NK T cells associated with disease development in autoimmune-prone mice, J Immunol, vol.156, pp.4035-4075, 1996.

K. Takeda and G. Dennert, The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms, Journal of Experimental Medicine, vol.177, issue.1
DOI : 10.1084/jem.177.1.155

J. Gombert, A. Herbelin, E. Tancr-ede-bohin, M. Dy, C. Carnaud et al., Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse, European Journal of Immunology, vol.19, issue.12, pp.2989-98, 1996.
DOI : 10.1002/eji.1830261226

K. Hammond, D. Pellicci, L. Poulton, O. Naidenko, A. Scalzo et al., CD1d-Restricted NKT Cells: An Interstrain Comparison, The Journal of Immunology, vol.167, issue.3, pp.1164-73, 2001.
DOI : 10.4049/jimmunol.167.3.1164

S. Kojo, Y. Adachi, H. Keino, M. Taniguchi, and T. Sumida, Dysfunction of T cell receptor AV24AJ18+,BV11+ double-negative regulatory natural killer T cells in autoimmune diseases, Arthritis & Rheumatism, vol.9, issue.5, pp.1127-1165, 2001.
DOI : 10.1002/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W

Z. Ill-es, T. Kondo, J. Newcombe, N. Oka, T. Tabira et al., Differential Expression of NK T Cell V??24J??Q Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy, The Journal of Immunology, vol.164, issue.8, pp.4375-81, 2000.
DOI : 10.4049/jimmunol.164.8.4375

A. Kukreja, G. Cost, J. Marker, C. Zhang, Z. Sun et al., Multiple immuno-regulatory defects in type-1 diabetes, Journal of Clinical Investigation, vol.109, issue.1, pp.131-171, 2002.
DOI : 10.1172/JCI0213605

T. Sumida, A. Sakamoto, H. Murata, Y. Makino, H. Takahashi et al., Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis, Journal of Experimental Medicine, vol.182, issue.4, pp.1163-1171, 1995.
DOI : 10.1084/jem.182.4.1163

H. Van-der-vliet, V. Blomberg, B. Nishi, N. Reijm, M. Voskuyl et al., Circulating V??24+ V??11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage, Clinical Immunology, vol.100, issue.2, pp.144-152, 2001.
DOI : 10.1006/clim.2001.5060

H. Kikutani and S. Makino, The Murine Autoimmune Diabetes Model: NOD and Related Strains, Adv Immunol, vol.51, pp.285-322, 1992.
DOI : 10.1016/S0065-2776(08)60490-3

D. Godfrey, S. Kinder, P. Silvera, and A. Baxter, Flow Cytometric Study of T Cell Development in NOD Mice Reveals a Deficiency in ????TCR+CD4???CD8???Thymocytes, Journal of Autoimmunity, vol.10, issue.3, pp.279-85, 1997.
DOI : 10.1006/jaut.1997.0129

B. Wang, Y. Geng, and C. Wang, Cd1-Restricted Nk T Cells Protect Nonobese Diabetic Mice from Developing Diabetes, The Journal of Experimental Medicine, vol.163, issue.3, pp.313-333, 2001.
DOI : 10.1084/jem.188.8.1529

A. Lehuen, O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud et al., Overexpression of Natural Killer T Cells Protects V??14-J??281 Transgenic Nonobese Diabetic Mice against Diabetes, The Journal of Experimental Medicine, vol.110, issue.10, pp.1831-1840, 1998.
DOI : 10.1126/science.274.5284.50

J. Cain, J. Smith, J. Ondr, B. Wang, and J. Katz, NKT Cells and IFN-?? Establish the Regulatory Environment for the Control of Diabetogenic T Cells in the Nonobese Diabetic Mouse, The Journal of Immunology, vol.176, issue.3, pp.1645-54, 2006.
DOI : 10.4049/jimmunol.176.3.1645

L. Beaudoin, V. Laloux, J. Novak, B. Lucas, and A. Lehuen, NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic ?? Cells, Immunity, vol.17, issue.6, pp.725-761, 2002.
DOI : 10.1016/S1074-7613(02)00473-9

S. Sharif, G. Arreaza, P. Zucker, Q. Mi, J. Sondhi et al., Activation of natural killer T cells by alphagalactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes, Nature Medicine, vol.7, issue.9, pp.1057-62, 2001.
DOI : 10.1038/nm0901-1057

M. Rapoport, A. Jaramillo, D. Zipris, A. Lazarus, D. Serreze et al., Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice, Journal of Experimental Medicine, vol.178, issue.1, pp.87-99, 1993.
DOI : 10.1084/jem.178.1.87

V. Laloux, L. Beaudoin, D. Jeske, C. Carnaud, and A. Lehuen, NK T Cell-Induced Protection Against Diabetes in V??14-J??281 Transgenic Nonobese Diabetic Mice Is Associated with a Th2 Shift Circumscribed Regionally to the Islets and Functionally to Islet Autoantigen, The Journal of Immunology, vol.166, issue.6, pp.3749-56, 2001.
DOI : 10.4049/jimmunol.166.6.3749

K. Hammond, L. Poulton, L. Palmisano, P. Silveira, D. Godfrey et al., (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10, The Journal of Experimental Medicine, vol.158, issue.7, pp.1047-56, 1998.
DOI : 10.1084/jem.186.1.109

V. Laloux, L. Beaudoin, C. Ronet, and A. Lehuen, Phenotypic and Functional Differences Between NKT Cells Colonizing Splanchnic and Peripheral Lymph Nodes, The Journal of Immunology, vol.168, issue.7, pp.3251-3259, 2002.
DOI : 10.4049/jimmunol.168.7.3251

L. Beaudoin, D. J. Ghazarian, L. Simoni, Y. Boitard, C. Lehuen et al., Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes, European Journal of Immunology, vol.22, issue.5, pp.1454-66, 2014.
DOI : 10.1002/eji.201343910

M. Falcone, F. Facciotti, N. Ghidoli, P. Monti, S. Olivieri et al., Up-Regulation of CD1d Expression Restores the Immunoregulatory Function of NKT Cells and Prevents Autoimmune Diabetes in Nonobese Diabetic Mice, The Journal of Immunology, vol.172, issue.10, pp.5908-5924, 2004.
DOI : 10.4049/jimmunol.172.10.5908

L. Ghazarian, D. J. Beaudoin, L. Larsson, P. Puri, R. Van-rooijen et al., Protection Against Type 1 Diabetes Upon Coxsackievirus B4 Infection and iNKT-Cell Stimulation: Role of Suppressive Macrophages, Diabetes, vol.62, issue.11, pp.3785-96, 2013.
DOI : 10.2337/db12-0958
URL : https://hal.archives-ouvertes.fr/tel-01071267

G. Chen, G. Han, J. Wang, R. Wang, R. Xu et al., Natural Killer Cells Modulate Overt Autoimmunity to Homeostasis in Nonobese Diabetic Mice after Anti-CD3 F(ab???)2 Antibody Treatment through Secreting Transforming Growth Factor-??, The American Journal of Pathology, vol.175, issue.3
DOI : 10.2353/ajpath.2009.080488

P. H?-oglund, J. Mintern, C. Waltzinger, W. Heath, C. Benoist et al., Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes, The Journal of Experimental Medicine, vol.76, issue.2, pp.331-340, 1999.
DOI : 10.2337/diacare.46.10.1542

L. Ghazarian, D. J. Simoni, Y. Beaudoin, L. Lehuen, and A. , Prevention or acceleration of type 1 diabetes by viruses, Cellular and Molecular Life Sciences, vol.116, issue.1???2, pp.239-55, 2013.
DOI : 10.1007/s00018-012-1042-1

J. Diana, V. Brezar, L. Beaudoin, M. Dalod, A. Mellor et al., Viral infection prevents diabetes by inducing regulatory T cells through NKT cell???plasmacytoid dendritic cell interplay, The Journal of Experimental Medicine, vol.958, issue.4, pp.729-774, 2011.
DOI : 10.1016/j.pt.2007.10.006
URL : https://hal.archives-ouvertes.fr/hal-00608142

Y. Chen, C. Choisy-rossi, T. Holl, H. Chapman, G. Besra et al., Activated NKT Cells Inhibit Autoimmune Diabetes through Tolerogenic Recruitment of Dendritic Cells to Pancreatic Lymph Nodes, The Journal of Immunology, vol.174, issue.3, pp.1196-204, 2005.
DOI : 10.4049/jimmunol.174.3.1196

R. Spolski and W. Leonard, Cytokine mediators of Th17 function, European Journal of Immunology, vol.181, issue.3
DOI : 10.1002/eji.200839066

K. Happel, M. Zheng, E. Young, L. Quinton, E. Lockhart et al., Cutting Edge: Roles of Toll-Like Receptor 4 and IL-23 in IL-17 Expression in Response to Klebsiella pneumoniae Infection, The Journal of Immunology, vol.170, issue.9, pp.4432-4438, 2003.
DOI : 10.4049/jimmunol.170.9.4432

K. Shibata, H. Yamada, H. Hara, K. Kishihara, and Y. Yoshikai, Resident V??1+ ???? T Cells Control Early Infiltration of Neutrophils after Escherichia coli Infection via IL-17 Production, The Journal of Immunology, vol.178, issue.7, pp.4466-72, 2007.
DOI : 10.4049/jimmunol.178.7.4466

J. Doisne, C. Becourt, L. Amniai, N. Duarte, L. Luduec et al., Skin and Peripheral Lymph Node Invariant NKT Cells Are Mainly Retinoic Acid Receptor-Related Orphan Receptor ??t+ and Respond Preferentially under Inflammatory Conditions, The Journal of Immunology, vol.183, issue.3, pp.2142-2151, 2009.
DOI : 10.4049/jimmunol.0901059
URL : https://hal.archives-ouvertes.fr/pasteur-00509628

M. Michel, A. Keller, C. Paget, M. Fujio, F. Trottein et al., iNKT cell population involved in airway neutrophilia, The Journal of Experimental Medicine, vol.17, issue.5, pp.995-1001, 2007.
DOI : 10.1002/eji.200535268
URL : https://hal.archives-ouvertes.fr/hal-00135759

J. Doisne, V. Soulard, C. Amniai, L. Henrot, P. Havenar-daughton et al., Cutting Edge: Crucial Role of IL-1 and IL-23 in the Innate IL-17 Response of Peripheral Lymph Node NK1.1- Invariant NKT Cells to Bacteria, The Journal of Immunology, vol.186, issue.2, pp.662-668, 2011.
DOI : 10.4049/jimmunol.1002725
URL : https://hal.archives-ouvertes.fr/hal-00591927

Y. Simoni, A. Gautron, L. Beaudoin, L. Bui, M. Michel et al., NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes, European Journal of Immunology, vol.208, issue.12, pp.3574-85, 2011.
DOI : 10.1002/eji.201141751
URL : https://hal.archives-ouvertes.fr/hal-00655397

L. Ghazarian, Y. Simoni, I. Magalhaes, and A. Lehuen, Invariant NKT cell development: focus on NOD mice, Current Opinion in Immunology, vol.27, pp.83-91, 2014.
DOI : 10.1016/j.coi.2014.02.004

S. Li, C. Joseph, C. Becourt, J. Klibi, S. Luce et al., Potential Role of IL-17-Producing iNKT Cells in Type 1 Diabetes, PLoS ONE, vol.56, issue.4, p.96151, 2014.
DOI : 10.1371/journal.pone.0096151.s004

L. Esteban, T. Tsoutsman, M. Jordan, D. Roach, L. Poulton et al., Genetic Control of NKT Cell Numbers Maps to Major Diabetes and Lupus Loci, The Journal of Immunology, vol.171, issue.6, pp.2873-2881, 2003.
DOI : 10.4049/jimmunol.171.6.2873

J. Fletcher, M. Jordan, S. Snelgrove, R. Slattery, F. Dufour et al., Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp4, The Journal of Immunology, vol.181, issue.5, pp.3400-3412, 2008.
DOI : 10.4049/jimmunol.181.5.3400

F. Facciotti, G. Ramanjaneyulu, M. Lepore, S. Sansano, M. Cavallari et al., Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus, Nature Immunology, vol.41, issue.5, pp.474-80, 2012.
DOI : 10.1002/eji.201040619

J. Gumperz, S. Miyake, T. Yamamura, and M. Brenner, Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer Staining, The Journal of Experimental Medicine, vol.158, issue.5, pp.625-661, 2002.
DOI : 10.1046/j.1365-2567.2000.00001.x

C. Montoya, D. Pollard, J. Martinson, K. Kumari, C. Wasserfall et al., Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11, Immunology, vol.177, issue.1, pp.1-14, 2007.
DOI : 10.1056/NEJMoa053614

P. Lee, K. Benlagha, L. Teyton, and A. Bendelac, Distinct Functional Lineages of Human V??24 Natural Killer T Cells, The Journal of Experimental Medicine, vol.195, issue.5, pp.637-678, 2002.
DOI : 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G

S. Hegde, J. Lockridge, Y. Becker, S. Ma, S. Kenney et al., Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients, J Autoimmun Hum Immunol, vol.376470, pp.262-270, 2009.

S. Wilson, S. Kent, K. Patton, T. Orban, R. Jackson et al., Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes, Nature, vol.391, pp.177-81, 1998.

P. Lee, A. Putnam, K. Benlagha, L. Teyton, P. Gottlieb et al., Testing the NKT cell hypothesis of human IDDM pathogenesis, Journal of Clinical Investigation, vol.110, issue.6, pp.793-800, 2002.
DOI : 10.1172/JCI0215832

S. Kent, Y. Chen, S. Clemmings, V. Viglietta, N. Kenyon et al., Loss of IL-4 Secretion from Human Type 1a Diabetic Pancreatic Draining Lymph Node NKT Cells, The Journal of Immunology, vol.175, issue.7, pp.4458-64, 2005.
DOI : 10.4049/jimmunol.175.7.4458

D. Chang, K. Osman, J. Connolly, A. Kukreja, J. Krasovsky et al., Sustained expansion of NKT cells and antigen-specific T cells after injection of ??-galactosyl-ceramide loaded mature dendritic cells in cancer patients, The Journal of Experimental Medicine, vol.163, issue.9, pp.1503-1520, 2005.
DOI : 10.1084/jem.20030451

H. Blumenfeld, R. Tohn, S. Haeryfar, Y. Liu, P. Savage et al., Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice, Clinical & Experimental Immunology, vol.7, issue.1, pp.121-154, 2011.
DOI : 10.1111/j.1365-2249.2011.04454.x

S. Motohashi, A. Ishikawa, E. Ishikawa, M. Otsuji, T. Iizasa et al., A Phase I Study of In vitro Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer, Clinical Cancer Research, vol.12, issue.20, pp.6079-86, 2006.
DOI : 10.1158/1078-0432.CCR-06-0114

A. Giongo, K. Gano, D. Crabb, N. Mukherjee, L. Novelo et al., Toward defining the autoimmune microbiome for type 1 diabetes, The ISME Journal, vol.8, issue.1, pp.82-91, 2011.
DOI : 10.1016/j.nut.2006.09.002

C. Brown, A. Davis-richardson, A. Giongo, K. Gano, D. Crabb et al., Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes, PLoS ONE, vol.186, issue.10, p.25792, 2011.
DOI : 10.1371/journal.pone.0025792.s007

C. Sorini and M. Falcone, Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes, Am J Clin Exp Immunol, vol.2, pp.156-71, 2013.

A. Kostic, D. Gevers, H. Siljander, T. Vatanen, T. Hy?-otyl?-ainen et al., The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes, Cell Host & Microbe, vol.17, issue.2, pp.260-73, 2015.
DOI : 10.1016/j.chom.2015.01.001

L. Loh, M. Ivarsson, J. Micha?-elsson, J. Sandberg, and D. Nixon, Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine, Mucosal Immunology, vol.7, issue.5, pp.1233-1276, 2014.
DOI : 10.1155/1998/12421

S. Zeissig and R. Blumberg, Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces, Current Opinion in Immunology, vol.25, issue.6, pp.690-696, 2013.
DOI : 10.1016/j.coi.2013.09.012

J. Markle, D. Frank, S. Mortin-toth, C. Robertson, L. Feazel et al., Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity, Science, vol.339, issue.6123, pp.1084-1092, 2013.
DOI : 10.1126/science.1233521

M. Terabe, J. Swann, E. Ambrosino, P. Sinha, S. Takaku et al., A nonclassical non-V??14J??18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance, The Journal of Experimental Medicine, vol.58, issue.12, pp.1627-1660, 2005.
DOI : 10.1172/JCI200419836

N. Duarte, M. Stenstr?-om, S. Campino, M. Bergman, M. Lundholm et al., Prevention of Diabetes in Nonobese Diabetic Mice Mediated by CD1d-Restricted Nonclassical NKT Cells, The Journal of Immunology, vol.173, issue.5, pp.3112-3120, 2004.
DOI : 10.4049/jimmunol.173.5.3112

L. Subramanian, H. Blumenfeld, R. Tohn, D. Ly, C. Aguilera et al., NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1

N. Kadri, E. Korpos, S. Gupta, C. Briet, L. L?-ofbom et al., CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1-Dependent Regulation of Type 1 Diabetes, The Journal of Immunology, vol.188, issue.7, pp.3138-3187, 2012.
DOI : 10.4049/jimmunol.1101390

D. Mathis, Immunological Goings-on in Visceral Adipose Tissue, Cell Metabolism, vol.17, issue.6, pp.851-860, 2013.
DOI : 10.1016/j.cmet.2013.05.008

S. Tateya, F. Kim, and Y. Tamori, Recent advances in obesityinduced inflammation and insulin resistance, Front Endocrinol (Lausanne), vol.4, p.93, 2013.

L. Lynch, O. Shea, D. Winter, D. Geoghegan, J. Doherty et al., cells amass in human omentum and are depleted in patients with cancer and obesity, European Journal of Immunology, vol.67, issue.7, pp.1893-901, 2009.
DOI : 10.1002/eji.200939349

L. Lynch, M. Nowak, B. Varghese, J. Clark, A. Hogan et al., Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue, Immunity Nat Immunol, vol.3716, pp.574-87, 2012.

H. Schipper, M. Rakhshandehroo, S. Van-de-graaf, K. Venken, A. Koppen et al., Natural killer T cells in adipose tissue prevent insulin resistance, Journal of Clinical Investigation, vol.122, issue.9, pp.3343-54, 2012.
DOI : 10.1172/JCI62739DS1

K. Ohmura, N. Ishimori, Y. Ohmura, S. Tokuhara, A. Nozawa et al., Natural Killer T Cells Are Involved in Adipose Tissues Inflammation and Glucose Intolerance in Diet-Induced Obese Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.2, pp.193-202, 2010.
DOI : 10.1161/ATVBAHA.109.198614

B. Mantell, M. Stefanovic-racic, X. Yang, N. Dedousis, I. Sipula et al., Mice Lacking NKT Cells but with a Complete Complement of CD8+ T-Cells Are Not Protected against the Metabolic Abnormalities of Diet-Induced Obesity, PLoS ONE, vol.49, issue.6, p.19831, 2011.
DOI : 10.1371/journal.pone.0019831.g006